Please login to the form below

Not currently logged in
Email:
Password:

IAS

This page shows the latest IAS news and features for those working in and with pharma, biotech and healthcare.

Biogen spin-out makes first acquisition

Biogen spin-out makes first acquisition

TNT009 is currently in a phase Ia/Ib study for CAD and also has potential in other diseases, including warm autoimmune haemolytic anaemia, antibody-mediated rejection of transplants and bullus pemphigoid

Latest news

More from news
Approximately 1 fully matching, plus 69 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OPEN Access Consulting

OPEN Access Consulting is a specialist market access agency within the OPEN Health Group. As value communications experts we specialise...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics